Your browser doesn't support javascript.
loading
Telephone risk-based eligibility assessment for low-dose CT lung cancer screening.
Dickson, Jennifer L; Hall, Helen; Horst, Carolyn; Tisi, Sophie; Verghese, Priyam; Mullin, Anne-Marie; Teague, Jonathan; Farrelly, Laura; Bowyer, Vicky; Gyertson, Kylie; Bojang, Fanta; Levermore, Claire; Anastasiadis, Tania; Sennett, Karen; McCabe, John; Devaraj, Anand; Nair, Arjun; Navani, Neal; Callister, Matthew Ej; Hackshaw, Allan; Quaife, Samantha L; Janes, Sam M.
Afiliação
  • Dickson JL; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
  • Hall H; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
  • Horst C; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
  • Tisi S; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
  • Verghese P; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
  • Mullin AM; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
  • Teague J; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
  • Farrelly L; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
  • Bowyer V; University College London Hospitals NHS Foundation Trust, London, UK.
  • Gyertson K; University College London Hospitals NHS Foundation Trust, London, UK.
  • Bojang F; University College London Hospitals NHS Foundation Trust, London, UK.
  • Levermore C; University College London Hospitals NHS Foundation Trust, London, UK.
  • Anastasiadis T; Tower Hamlets Clinical Commissioning Group, London, UK.
  • Sennett K; Killick Street Health Centre, London, UK.
  • McCabe J; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
  • Devaraj A; Department of Radiology, Royal Brompton Hospital, London, UK.
  • Nair A; National Heart and Lung Institute, Imperial College London, London, UK.
  • Navani N; University College London Hospitals NHS Foundation Trust, London, UK.
  • Callister ME; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.
  • Hackshaw A; University College London Hospitals NHS Foundation Trust, London, UK.
  • Quaife SL; Cancer Research UK and UCL Cancer Trials Centre, University College London, London, UK.
Thorax ; 77(10): 1036-1040, 2022 10.
Article em En | MEDLINE | ID: mdl-35863766
Eligibility for lung cancer screening (LCS) requires assessment of lung cancer risk, based on smoking history alongside demographic and medical factors. Reliance on individual face-to-face eligibility assessment risks inefficiency and costliness. The SUMMIT Study introduced a telephone-based lung cancer risk assessment to guide invitation to face-to-face LCS eligibility assessment, which significantly increased the proportion of face-to-face attendees eligible for LCS. However, levels of agreement between phone screener and in-person responses were lower in younger individuals and minority ethnic groups. Telephone-based risk assessment is an efficient way to optimise selection for LCS appointments but requires further iteration to ensure an equitable approach.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article